Remove 2017 Remove Cannabis Remove Clinical Trials Remove Treatment
article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

article thumbnail

Medical Marijuana Offers Hope for Treatment of PTSD

FloridaMarijuana.net

According to a 2017 report published by the National Academies of Sciences , PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. Treatment usually aims at reducing reactions and to diminishing the acuity of the reactions.

Treatment 182
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

1 in 5 Parkinson’s Patients Use Cannabis

CannaMD

However, little is known about these patients’ thoughts and experiences related to cannabis, or its perceived effect on the disease’s symptoms. In addition, cannabis users participating in the survey were younger by an average of 3 years in age than non-users in the survey. Why Do Parkinson’s Patients Use Marijuana?

Patients 105
article thumbnail

Cannabis Helps, Say Over Half of Parkinson’s Patients Who Use It

The Cannigma

This article was originally published on Analytical Cannabis and appears here with permission. . In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition.

article thumbnail

Medical cannabis studies offer hope to opioid users

Healer

Some researchers believe cannabis can help wean prescription opioid users off the addictive and potentially deadly drugs. Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management.

article thumbnail

Senators Call For Report On State Of Psychedelic Research

Cannabis Law Report

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] In 2017, FDA granted a request for Breakthrough Therapy designation for MDMA to treat PTSD. Defining Psychedelics.

article thumbnail

European Medicinal Cannabis Association (EUMCA) Say Germany Has The Cannabis Model The EU Should Adopt

Cannabis Law Report

Euractiv report… Germany’s regulatory approach to medical cannabis is good practice and should be replicated across Europe, according to newly-born European Medicinal Cannabis Association (EUMCA). Lack of clinical trials is a major reason why doctors are cautious about the drug. Read full story.